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Background: In the paediatric population, pain and distress associated with burn injuries during wound care
procedures remain a constant challenge. Although silver dressings are the gold standard for burn care in
Australasia, very few high-level trials have been conducted that compare silver dressings to determine which will
provide the best level of care clinically. Therefore, for paediatric patients in particular, identifying silver dressings that
are associated with lower levels of pain and rapid wound re-epithelialisation is imperative. This study will determine
whether there is a difference in time to re-epithelialisation and pain and distress experienced during wound care
procedures among Acticoat™, Acticoat™ combined with Mepitel™ and Mepilex Ag™ dressings for acute, paediatric
partial thickness burns.
Methods/Design: Children aged 0 to 15 years with an acute partial thickness (superficial partial to deep partial
thickness inclusive) burn injury and a burn total body surface area of ≤10% will be eligible for the trial. Patients will
be randomised to one of the three dressing groups: (1) Acticoat™ or (2) Acticoat™ combined with Mepitel™ or
(3) Mepilex Ag™. A minimum of 28 participants will be recruited for each treatment group. Primary measures of
pain, distress and healing will be repeated at each dressing change until complete wound re-epithelialisation occurs
or skin grafting is required. Additional data collected will include infection status at each dressing change, physical
function, scar outcome and scar management requirements, cost effectiveness of each dressing and staff
perspectives of the dressings.
Discussion: The results of this study will determine the effects of three commonly used silver and silicone burn
dressing combinations on the rate of wound re-epithelialisation and pain experienced during dressing procedures
in acute, paediatric partial thickness burn injuries.
Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12613000105741
Keywords: Child, Burn injuries, Partial thickness, Silver dressings, Healing, Pain, Distress, Randomised clinical trialBackground
The ultimate goal of burn wound healing is to promote
early closure as this has considerable influence on the
long-term quality and appearance of a hypertrophic scar.
It has been demonstrated that even scars considered small
in size can contribute to negative psychosocial outcomes
for children, hence the importance of effective wound
healing techniques [1,2]. The relationship between scar* Correspondence: e.geekee@uq.edu.au
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reproduction in any medium, provided the orformation and time taken to re-epithelialise in children is
well understood by burn clinicians. According to Cubison
and colleagues [3], partial thickness burns that re-
epithelialise within the optimal time period of 10–14 days
generally do so without scarring, and those taking more
than 3 weeks will invariably scar. Burns re-epithelialising
at between 2 and 3 weeks will have variable amounts of
scar tissue laid down depending on many factors including
skin type, anatomical location of the burn and age of the
child [3].
Children whose burn wounds re-epithelialise at more
than 3 weeks post-injury are at a high risk of residual orl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Gee Kee et al. Trials 2013, 14:403 Page 2 of 8
http://www.trialsjournal.com/content/14/1/403hypertrophic scarring [3]. Scar management therapy fa-
cilitated by occupational therapists to manage and pre-
vent hypertrophic scarring currently involves the use of
various types of silicone contact media, pressure gar-
ments and splints. Engagement in scar management
therapy typically occurs for 18 months or until scars
reach maturity. While these scar management tech-
niques are successful for some children in managing
scars, there are inevitably children who require ongoing
treatment of their scar tissue as they grow older. Scars
generally do not grow with the child, and if situated
around a joint, can lead to joint contracture and loss of
function, resulting in ongoing scar reconstruction to
keep up with the child’s growing body [4]. Therefore the
initial care of the burn wound and choice of burn dress-
ing are vital in creating the ideal healing environment to
ensure rapid re-epithelialisation of the wound and to
avoid the possibility of hypertrophic scarring.
In the past 30–40 years, children with burns were
treated with daily baths, dressing changes and antisep-
tic or topical silver sulfadiazine-based creams; however
even with appropriate pain relief these procedures were
often very distressing and painful for children [5]. It
has been well documented that burn wound care pro-
cedures are highly traumatic for children and the re-
sultant stress has been shown to interrupt and delay
the cascade of wound healing [6]. Decreasing the pain
and distress experienced during a dressing change pro-
cedure can have positive implications psychosocially
for the child as well as encouraging re-epithelialisation
of the wound within the optimal healing timeframe [7].
Therefore in the paediatric population, careful atten-
tion also needs to be made concerning choosing a
dressing that can be applied and removed with minimal
pain and stress to the child. A dressing that requires in-
frequent reapplication also has obvious benefits by de-
creasing the number of dressing change procedures the
child has to undergo.
Small to medium-sized partial thickness burns are
mainly managed in the outpatient setting using specia-
lised dressings that promote moist wound healing and
prevent wound infection [8]. Unfortunately the antibac-
terial agents in burn dressings are also cytotoxic to kera-
tinocytes; therefore a fine balance is required between
the prevention of a wound infection and the promotion
of wound healing [9]. Despite the known cytotoxic
effects of antibacterial dressings, they help prevent
not only infections (which can delay the rate of re-
epithelialisation) but also the possibility of toxic shock
syndrome (TSS), which is most likely to occur in the
first 3 days post-burn injury and if left untreated can be
fatal [10-12].
The standard of care in burn dressings for small to
medium partial thickness burns has changed in the last10–15 years. Currently silver-depositing fabric and foam
dressings are the gold standard used to manage the bio-
burden of a wound, with or without a silicone skin inter-
face [13]. Acticoat™ (Smith & Nephew, Hull, UK) has
been available since the 1990s and is the most widely
used silver dressing in the developed world. It needs to
be moistened with sterile water to promote the release
of silver onto the burn wound and can be left on for 3–
4 days. Acticoat™ may be used alone or in combination
with a Mepitel™ dressing (Mölnlycke Healthcare, Mik-
keli, Finland), which acts as a non-stick interface be-
tween Acticoat™ and the burn wound. Mepitel™ is a
silicone-coated nylon grid product that utilises non-stick
Safetac™ technology to reduce the pain and trauma expe-
rienced by children during dressing changes and the
amount of silver in direct contact with the wound.
Mepilex Ag™ (Mölnlycke Healthcare, Mikkeli, Finland)
has been available since 2007 and is a soft foam, silver-
impregnated dressing that absorbs exudate and main-
tains a moist wound environment [14]. Silver particles
are released from Mepilex Ag™ when it is moistened
from direct contact with wound exudate. It also has a
silicone Safetac™ interface layer incorporated within its
design that, in a similar way to the Mepitel™, serves to
promote easy removal of the dressing and reduce pain
and trauma during dressing changes [14].
Many trials have been conducted regarding the efficacy
of silver dressings for treating burn injuries, using top-
ical silver sulfadiazine applications as the control or
comparator dressing. However, these silver sulfadiazine
applications have been shown to delay re-epithelialisation
and are painful to apply and remove, indicating the possi-
bility of bias in the results of these trials [13,15,16]. Add-
itionally, despite the large number of silver-impregnated
burn dressings that have become available on the mar-
ket, very few high-level trials have been conducted that
compare these dressings in paediatric or adult patients.
For paediatric patients in particular, identifying silver
dressings that are associated with lower levels of pain,
require fewer reapplications and promote a fast rate of
re-epithelialisation is vital.
The aim of this study is to then determine whether
one of three silver- and silicone-containing burn dress-
ings—Acticoat™, Acticoat™ combined with Mepitel™ or
Mepilex Ag™—will be more effective in terms of pain ex-
perienced and the rate of re-epithelialisation of acute,
partial thickness burns in children.
The following protocol for this study has been re-
ported as per CONSORT guidelines [17].
Methods/Design
Ethics approval
This study is registered with the Australian New Zealand
Clinical Trials Registry (ACTRN12613000105741) and
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(Royal Children’s Hospital) Human Research Ethics
Committee and The University of Queensland Ethics
Committee.
Study design
This study is a prospective, randomised controlled trial.
Participants will be randomised to receive one of three
commonly used dressings for burn wounds, (1) Acticoat™,
(2) Acticoat™ and Mepitel™ combined or (3) Mepilex Ag™,
in order to determine the effects of the dressings on pain
and the rate of re-epithelialisation in acute, partial thickness
burns in children. It is hypothesised that silver dressings
with a silicone interface, compared to no silicone interface,
will decrease the time to re-epithelialisation of a burn injury
and decrease the amount of pain and distress experienced
during dressing changes within a paediatric population.
The design of data collection is displayed in Figure 1.
Study setting
Participants for this study will be recruited from the
Royal Children’s Hospital, Brisbane, Australia. Children
presenting to the Department of Emergency (DEM)
from March 2013 will be screened on presentation by a
surgical registrar for eligibility to this study.
Participants
Inclusion criteria
Children who are aged 0 to 15 years with an acute par-
tial thickness (superficial partial to deep partial thickness
inclusive) burn injury and a burn total body surface area
of ≤10%, presenting at the DEM within the first 72 h
post-injury will be considered for inclusion in this study.
Exclusion criteria
Children will be excluded from this study if they present
>72 h post burn; have received silver dressings prior to
presentation at the Royal Children’s Hospital; have sus-
tained a superficial (erythema only) or full thickness
burn; have sustained a chemical or friction burn; present
with cold, flu or viral symptoms (e.g. upper respiratory
tract infection); have received inappropriate first aid (e.g.
dirty water); have a known reaction to silver products;
are non-English speaking; have a cognitive impairment;
or are currently involved with Department of Communi-
ties (Child Safety). Additionally, any children who have
burn wounds requiring grafting, contract an infection or
need to change dressing type during the course of their
treatment will only have data collected up until that
point in time, as these changes in clinical care will void
the intervention they have been randomised into for the
study. These exclusions will not be known until after the
child is recruited and randomised because of the vari-
ability of patient and wound management needs.Apart from the dressings received, children participat-
ing in this study will receive the same standard medical
care as those children not participating in the study.
Recruitment
A surgical registrar will be notified of a patient with a
burn injury by DEM staff and will then determine the
patient’s eligibility according to study criteria. The po-
tential participants and their parents/caregivers will be
notified of their eligibility to participate in this study by
the registrar. Parents/caregivers will then be asked if a
member of the research team can speak to them about
the study. Informed caregiver consent and child assent
(for children 6 years and above) will be gained by an in-
vestigator on the study after a discussion with the child
and their caregiver regarding the information in the Pa-
tient Information Sheet. Once consent has been gained,
the investigator will randomise the patient to one of the
three dressing treatment arms. Randomisation will be
completed using a computerised random number gener-
ator and randomisations will be enclosed in sealed,
opaque envelopes by an independent party. All dressings
will be carried out by staff experienced in burn dressing
application. Baseline measures (pain and behavioural
scores from child, nurse and parent, pulse rate and re-
spiratory rate) will be recorded by the primary investiga-
tor prior to and after the dressing has been applied. The
patient will then present at our burn centre every 3–
4 days for subsequent dressing changes. Any analgesia
given to the patient will be recorded.
The first 3 days post-burn injury often have the highest
risk of toxic shock syndrome, which can be potentially
fatal if left untreated [10,18]. While the incidence rate of
toxic shock syndrome at our burn centre is extremely low
to non-existent, phone calls will be made to each partici-
pant by the primary investigator within this period. A set
of standardised questions will be used to screen for any
toxic shock syndrome symptoms and to assess how the
child and their parents or caregivers are managing the
dressing, and all responses will be recorded.
Intervention
The intervention will be one of the Acticoat™, Acticoat™
combined with Mepitel™ or Mepilex Ag™ dressing arms
that the participant is randomised into on presentation.
This dressing will then be used to treat the burn wound
and will be replaced every 3–4 days at each dressing
change until re-epithelialisation occurs or grafting is re-
quired. The dressings will be applied according to the
manufacturer’s instructions.
Data collection
Demographic information and clinical details will be
obtained from the caregiver and the patient’s chart
Assessed for eligibility 
Excluded  
Not meeting inclusion criteria 
Declined to participate
Other reasons
Ultrasound scan of burn area
Patient and Observer Scar 
Assessment scale
3D photograph
Allocated to ActicoatTM
dressing
Dressing change every 3-4 
days until healing or graft
Pain and distress measures
Visitrak tracing and 3D 
photograph
Enrolment
Randomisation
3 month follow-Up
6 month follow-up
Allocated to ActicoatTM and 
MepitelTM dressing
Dressing change every 3-4 
days until healing or graft
Pain and distress measures
Visitrak tracing and 3D 
photograph
Allocated to Mepilex AgTM
dressing 
Dressing change every 3-4 
days until healing or graft
Pain and distress measures
Visitrak tracing and 3D 
photograph
Ultrasound scan of burn area
Patient and Observer Scar 
Assessment scale
3D photograph
Ultrasound scan of burn area
Patient and Observer Scar 
Assessment scale
3D photograph
Ultrasound scan of burn area
Patient and Observer Scar 
Assessment scale
3D photograph
Ultrasound scan of burn area
Patient and Observer Scar 
Assessment scale
3D photograph
Ultrasound scan of burn area
Patient and Observer Scar 
Assessment scale
3D photograph
Figure 1 Data collection flowchart. The chronological timing and order of data collection within the burn wound care procedure framework.
Gee Kee et al. Trials 2013, 14:403 Page 4 of 8
http://www.trialsjournal.com/content/14/1/403regarding the mechanism of the burn injury, site of the
injury, total body surface area of the burn and first aid
the patient received. Children over the age of 4 years will
be given the Ditto™ (virtual reality) device (Diversionary
Therapy Technologies, Queensland, Australia) to engage
in the “Bobby got a Burn” procedural preparation story
at their first dressing change. These children may also
engage in a choice of games or stories on the Ditto™ dur-
ing all dressing changes. At the first dressing change
only, each participant will have their burn/s scanned
using the LDI2-BI (VR) Laser Doppler Imager (LDI)
(Moor Instruments, Axminster, Devon, UK), which mea-
sures wound depths (in blood perfusion units) as a per-
centage of total wound area. The laser Doppler imager
scan will provide an objective assessment of burn depth
to enable a comparison of treatment group demograph-
ics [19]. Participants who have burn wounds on differentbody parts will have separate scans completed for each
body part involved. If burn wounds are circumferential
or across curved areas, more than one scan will be taken
at the frontal, lateral and medial aspects to obtain an ac-
curate scan. In addition, blinded photo reviews of burn
depth will be undertaken by a panel of burn specialists
(consultants and nurses).
At each dressing change appointment, pain, behaviour
and physiological measures (pulse rate and respiratory
rate) will be taken before and after dressing removal and
before and after the re-application of a new dressing.
The time taken for the dressing removal, cleaning and
re-application procedure, the number of nurses required
to complete the entire procedure, quantity of dressings
used and analgesia given to the participant will be re-
corded. A tracing of the wound using Visitrak™ grids
(Smith & Nephew, Hull, UK) and a photograph using
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will be taken. Nursing staff treating the child will be sur-
veyed on a 5-point Likert scale regarding the ease of use
of the dressing for that particular child. Parents or care-
givers and children over the age of 8 years will be sur-
veyed on a 5-point Likert scale regarding their physical
function while wearing the dressing.
All participants in the study will have their dressings
changed every 3–4 days at our burn centre as a standard
measure. This protocol will be followed until full re-
epithelialisation of the wound occurs or grafting of the
wound is required [20]. After full re-epithelialisation oc-
curs, participants will be followed up at 3 months and
then 6 months to assess skin appearance and/or the
presence of scarring.
Primary outcome measures
Days to re-epithelialisation
The number of days from the burn injury date until
wound re-epithelialisation occurs, surface area of the
wound and percentage of wound re-epithelialisation will
be calculated by four methods: (1) clinical judgement
from the consultant; (2) use of Visitrak™ grids; (3) 3D
camera photographs and analysis on specialist computer
software; and (4) blinded review of the 3D photographs
by a panel of burn specialists (consultants and nurses).
The 3D photographs and Visitrak™ tracings will be taken
of a participant’s burn wound at every dressing change.
A ruler will be included in all 3D photographs for meas-
urement calibration in the associated software package
Dermapix™ (Quantificare, Cedex, France). The 3D photo-
graphs will be analysed by the primary investigator on the
Dermapix™ software programme to calculate the burn
wound surface area and area of re-epithelialisation of
the wound from each dressing change. The Visitrak™ will
also be used to trace around total burn area and re-
epithelialised areas of the burn wounds at each dressing
change in order to calculate wound surface area and per-
centage of re-epithelialisation.
A blinded review of the 3D photographs will be under-
taken by a panel of burn wound specialists (consultants
and nursing staff ) who will assess the progress of re-
epithelialisation and appearance of each participant’s
burn wound after data collection has been completed.
Pain
Pain and distress will assessed by obtaining: (1) the par-
ticipant’s self-report of pain intensity using the Faces
Pain Scale-Revised (FPS-R) (if participant is aged 3 years
or over) [21]; (2) the parent’s report of the participant’s
pain intensity using a Visual Analogue Scale-Pain
(VAS-P) (alternatively, if participants are aged 8 years
or over they will complete the VAS-P in lieu of the
caregiver) [22]; (3) the nurse’s observational rating ofthe participant’s pain and distress using the Face, Legs,
Activity, Cry, Consolability (FLACC) scale [23]; and (4)
pulse and respiratory rates of the participant.. All four
of these measures will be taken before and after dress-
ing removal and before and after dressing application.
Pulse and respiratory rates will be recorded once at
each time point to provide an objective measure of pain
and distress in participants, as increases in these
physiological measures have been shown to be indica-
tive of pain and distress [6,24] Any analgesic and/or
sedative medication administered to the participant at
each dressing change will also be recorded.
Face scales are particularly useful for obtaining self-
report pain scores from younger children as they have
been reported to be easier to follow than other types of
self-report scales and are well-validated measures [25].
The FPS-R is clinically valid for a paediatric population
and was chosen over other faces pain scales because of
its psychometrically sound characteristics including the
exclusion of smiling faces or tears, thus eliminating the
possible confusion of pain intensity and affect by children
[21]. The VAS-P is a valid and reliable self-report measure
of acute pain in children over the age of 8 years [22]. The
VAS-P is not valid for children under the age of 8, but is
valid as a parent-report measure of pain and therefore par-
ents and caregivers of these children in this study will in-
stead score their child’s pain level [22]. The FLACC scale
is a valid and reliable behavioural observer-report (nurse
or health professional) measure of a child’s pain. Self-
reports of pain intensity can be difficult to ascertain and
inaccurate when a child is receiving sedative and analgesic
medications or is too young to verbalise their pain level;
therefore the use of the FLACC scale can be a suitable
and accurate alternative [23].
Secondary outcome measures
Physical function
A self-report of the participants’ ease of movement while
wearing the dressing will be obtained using a 5-point
Likert scale question from children over the age of 8 years
or their caregiver at the first dressing change [26].
Grafting
A note will be recorded if a participant’s wound requires
grafting. Data collection will cease on that date for the
participant as different dressings are used for wounds
that are grafted; however all data preceding that point
will be included for analysis.
Infection
At each dressing change, the wound will be assessed
clinically by the consultant. If the consultant deems an
infection to be present, a swab will be taken from the
wound for confirmation and identification.
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At each dressing change, nursing time to apply the
dressing, the amount and size of each dressing used, and
any other resources required will be recorded and a
cost-analysis will then be calculated. Additionally, dress-
ings required for scar management will also be recorded
and analysed.
Scar assessment
If further scar management treatment is required after
full re-epithelialisation of the burn injury has occurred,
a referral will be made by the treating consultant to the
scar management clinic. At 3 months following full
re-epithelialisation of the burn injury, a face-to-face
follow-up will be completed with all participants to
conduct a skin and/or scar review in conjunction with
Occupational Therapy. An ultrasound scan (BT12
Venue 40 MSK, GE Healthcare) [19] will be taken of
the burn area to measure the height of the scar, and
digital and 3D photographs will also be taken. The Pa-
tient and Observer Scar Assessment Scale will also be
completed with the child (if over the age of 6 years)
and/or caregiver. All scar management resources used
with the participant will be recorded for a cost-analysis.
At 6 months post-full re-epithelialisation, the same
measures will be repeated.
Burn centre staff perspectives on dressings
Nursing staff, consultants and occupational therapists
from our burn centre will be surveyed regarding their
opinions of the three dressings prior to the commence-
ment of data collection. The survey questions will be
standardised and consist of Likert scales, tick boxes with
a selection of responses and additional space for com-
ments regarding the dressings. Nursing staff will be sur-
veyed again using the same questions after data
collection has ceased to examine any changes in their
perceptions of the dressings after using all three for an
extended period of time.
Blinding
The dressing used for each participant cannot be
completely masked, as the Acticoat™ dressing stains
the healthy skin around a burn wound brown. The ex-
pert panel of burn wound specialists will be blinded
where possible; however the primary investigator and
expert panel may still be able to deduce what dressing
a participant received. The primary investigator will
also be present when dressings are being applied and
removed to obtain pain scores from the participant,
caregiver and nursing staff, and will see which dress-
ing is being used on the child. Wherever possible dur-
ing data collation and analysis, treatment groups will
be de-identified.Discontinuation/adverse events
The infection of the burn wound is a potential adverse
effect of any of the burn dressings. Infection rates at our
burn centre are extremely low; however if any adverse
effects such as infection occur, participants will only
have data collected up until that point in time analysed,
as clinical care (including dressing type) may change to
address the adverse event. Additionally, if a consultant
feels that a particular dressing is not appropriate for a
participant’s care, they may change to a different dress-
ing. If this occurs, data collection for this participant will
cease from this date. All data preceding this date will be
included for analysis.
Statistics
Sample size
The primary outcome measure will be days until wound
re-epithelialisation. Previous data in paediatric burn pa-
tients demonstrated re-epithelialisation within 15 (SD = 4)
days and a minimally clinically important difference is
3 days [6]. Thus sample size was calculated at 28 per
group at 80% power with an α of 0.05. Allowing for 20%
loss to follow-up, a total of 100 participants will be re-
quired. The burn centre treats 800 children per year
with burns so recruitment for this study should be
achievable within 1 year. This sample size will also be
adequate to find a significant difference in data collected
from pain scores, powered on data from a previous
study [6].
Data analysis
All statistical analyses will be conducted using SPSS 21
(IBM Corp., Armonk, NY, USA). Generalised linear
models, estimating variance appropriately for repeated
measures, will be used to determine whether there are
differences among the Acticoat™ group, the Acticoat™
combined with Mepitel™ group and the Mepilex Ag™
group in primary and secondary outcomes. Changes in
the intervention effects will be examined with burn
depth, burn total body surface area, mechanism of in-
jury, anatomical location of the burn, skin type, ease of
dressing removal and application and physical function
considered a priori to be of potential interest. All data
will be analysed as intention to treat and on a per proto-
col basis, with the intention to treat analysis being the
primary approach for this trial. Any missing data will be
handled using the multiple imputation method. All tests
will be two-tailed and only those with a p value <0.05
will be considered statistically significant.
Data storage
Data will be securely stored in a locked filing cabinet in
a secure area of Queensland Children’s Medical Research
Institute, The University of Queensland. Data will be
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data will be coded as missing, unknown or not applic-
able. The full data set will be cleaned and checked before
being locked for analysis. On completion of the study,
data will be kept for a period of 15 years in accordance
with NHMRC guidelines.
Discussion
Pain and distress during dressing change procedures re-
main a major challenge when treating acute paediatric
burn injuries and can have a negative effect on healing
[6]. Although silver dressings are the gold standard for
burn care in Australasia, very few high-level trials have
been completed comparing the clinical utilities of these
dressings, particularly in relation to pain and rates of re-
epithelialisation in paediatric burn patients. Additionally,
the majority of trials that are available on these dressings
only show the benefits of using these silver dressings in
comparison with silver sulfadiazine creams for burn in-
juries and are not specific to paediatric or adult patients
[15]. Therefore, for paediatric patients in particular,
identifying silver dressings that are associated with lower
levels of pain and rapid wound re-epithelialisation is im-
perative not only for clinical care, but also to facilitate
further evidence based practice in this field.
A clear link has been established between the rate of
re-epithelialisation of a burn wound and the risk of
hypertrophic scarring. Partial thickness burn injuries
that heal within 10–14 days are at a very low risk of de-
veloping hypertrophic scarring, whereas wounds that re-
epithelialise within 2 to 3 weeks will inevitably produce
some scar tissue, and those wounds taking more than
3 weeks to re-epithelialise are likely to result in hyper-
trophic scarring [3]. Given this knowledge, if there is a
silver dressing that is associated with a reduced time
for a burn injury to re-epithelialise, there is a possibility
that partial thickness burns can be healed within the
optimal time period of 10–14 days, which could subse-
quently reduce the risk of hypertrophic scarring and
the need for reconstructive surgery in paediatric pa-
tients with this depth of burn.
The associated pain experienced during dressing re-
moval and re-application by paediatric patients is a signifi-
cant problem for health professionals. Previous studies
have shown that an increase in pain, anxiety and distress
during various types of wound care procedures can have a
negative effect on the healing cascade [6,7,24]. This nega-
tive effect on the rate of re-epithelialisation in paediatric
patients with burn injuries may increase the likelihood of
hypertrophic scarring as a result of the injuries not
re-epithelialising in the optimal time period. It is therefore
imperative to identify a silver dressing that promotes a fast
rate of re-epithelialisation and that induces the least
amount of pain and discomfort on removal andapplication for paediatric patients. Dressings that are com-
fortable and easy to move in and that require infrequent
changes are also beneficial for the paediatric population.
While every precaution possible will be taken for this
study, there still may be some limitations involved with
data collection. All children recruited into the study will
have a laser Doppler imager scan taken of their burn
wound [19]. Although the scan can be completed for
children of any age, children are required to remain still
for a period of time with their wound exposed to the air
and free of dressings while the scan is being taken. Given
that this study is recruiting all children under the age of
16 years, completing these scans may be difficult if not
impossible in some circumstances because of the age of
the child and associated pain from the exposed wound.
Thus, to compensate for this limitation, a blinded photo
review of burn depth by a panel of burn specialists will
also be undertaken. Additionally, completing Visitrak™
tracings on some children may be a challenge, as they
are again required to remain still and may experience
pain or discomfort when the Visitrak™ grid is in direct
contact with their wound.
Significance of study
In Australasia, the standard of care in burn dressings for
small to medium partial thickness burns has changed
over the past 10–15 years. Currently, silver-containing
dressings are used as the gold standard of burn care to
prevent infection and promote healing. However, despite
the large number of silver burn dressings available on
the market, very few high level trials have been con-
ducted in paediatric or adult patients. This study aims to
determine the effect of Acticoat™, Acticoat™ combined
with Mepitel™ and Mepilex Ag™ burn dressings on the
rate of re-epithelialisation of partial thickness burn
wounds and pain and distress levels during the treat-
ment of these injuries in the paediatric population.
Trial status
This study commenced recruitment on 18 March 2013.
Completion of participant recruitment is planned by
December 2013 and data collection is likely to continue to
June 2014 (with data collection continuing until 6 months
post re-epithelialisation of participant’s burns).
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